
Otxone SL 500mg/125mg Injection
Marketer
Yew Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (125mg)
Overview Otxone SL 500mg/125mg Injection
Combiflox SL Injection (500mg/125mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection spread. Administration must be under a doctor's guidance; strict adherence to the prescribed schedule is crucial. Complete the entire course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Disclose all current medications to your physician prior to use. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption is inadvisable due to potential additive drowsiness. While driving ability is usually unaffected, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Otxone SL 500mg/125mg Injection
There is no text provided to rephrase.
Uses of Otxone SL 500mg/125mg Injection
Infections caused by bacteria
Major Benefits of Otxone SL 500mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Otxone SL 500mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Otxone SL 500mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Otxone SL 500mg/125mg Injection works:
Otxone SL injection (500mg/125mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby improving ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Otxone SL 500mg/125mg Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Otxone SL 500mg/125mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Otxone SL 500mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Otxone SL 500mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Otxone SL 500mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Otxone SL (500mg/125mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dose of Otxone SL (500mg/125mg) injection is not suggested for patients exhibiting mild or moderately compromised liver function.
What if you forget to take Otxone SL 500mg/125mg Injection :
Should you forget a scheduled dose of Otxone SL 500mg/125mg Injection, seek advice from your physician.
Facts to Know About Otxone SL 500mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
